Telo Therapeutics, Inc.
San Francisco, US · 1 known investors
Biotech
Founders & leadership
RG
Robert G. BlazejDirector
RB
Robert BellExecutive Officer, Director
JC
Joseph CostelloDirector
MD
Michael D. TaylorDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$4.7MraisedJun 2022 · 12 investors · BiotechnologyRule 506(b)
▶$4.7MraisedJun 2022 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert G. BlazejDirector
- Robert BellExecutive Officer, Director
- Joseph CostelloDirector
- Michael D. TaylorDirector
- Offering amount
- $10.2M
- Amount sold
- $4.7M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.